Renfu Medicine's Omega-3-Ethyl Acid Obtained FDA Approval Number
-
Last Update: 2020-06-25
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Pharmaceutical Network, June 17 - Renfu Pharmaceuticals announced on June 16 that the holding subsidiary Puracap Pharmaceutical LLC (hereinafter referred to as "U.SPuke") has recently received the U.SFDA approval number for omega-3-ethyl acid ester softgelsOmega-3-ethyl acid softgels are mainly used to reduce hypertriglyceride and triglycerideswith a low-fatdietAccording to IMS, thedrugtotal sales in the U.Smarket in 2019 will be about $120 million, with major manufacturers including Strides, Apotex, Amneal and TevaPuk filed an ANDA application for Omega-3-ethyl acid softgels in 2017 with a cumulative research and development investment of approximately $1.2 millionThis omega-3-ethyl acid softgel obtained the U.SFDA approval number, marking the U.SPuke in the U.Smarket sales of the product eligibilityAccording to the website of the State Drug Administration, there is no domestic production of omega-3-ethyl acid ethyl acetate preparations approved for sale, according to insight statistics, Abbott Trade (Shanghai) Co., Ltd., Sichuan Guofor pharmaceutical Co., Ltd., Chengdu ShengdiPharmaceuticalCo., Ltdhas submitted the drug's listing application
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
